BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24131912)

  • 41. [Therapy of alopecia areata with diphenylcyclopropenone].
    Kietzmann H; Hardung H; Christophers E
    Hautarzt; 1985 Jun; 36(6):331-5. PubMed ID: 3160683
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Infliximab-induced psoriasis in treatment of Crohn's disease-associated ankylosing spondylitis: case report and review of 142 cases.
    Famenini S; Wu JJ
    J Drugs Dermatol; 2013 Aug; 12(8):939-43. PubMed ID: 23986169
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral administration of cyclosporin A in patients with severe alopecia areata.
    Rallis E; Nasiopoulou A; Kouskoukis C; Roussaki-Schulze A; Koumantaki E; Karpouzis A; Arvanitis A
    Int J Tissue React; 2005; 27(3):107-10. PubMed ID: 16372476
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment of severe alopecia areata with topical applications of cyclosporin A].
    Mauduit G; Lenvers P; Barthélémy H; Thivolet J
    Ann Dermatol Venereol; 1987; 114(4):507-10. PubMed ID: 3619297
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is there a role for sulfasalazine in the treatment of alopecia areata?
    Bakar O; Gurbuz O
    J Am Acad Dermatol; 2007 Oct; 57(4):703-6. PubMed ID: 17610992
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Delightful hair growth after lung transplantation.
    Mannes GP; van der Bij W; de Boer WJ; Blanken R
    Transpl Int; 1995; 8(3):247-8. PubMed ID: 7626190
    [No Abstract]   [Full Text] [Related]  

  • 47. Development of miliary tuberculosis under infliximab in a patient with spondyloarthritis and suspected Crohn's disease.
    Koschny R; Junghanss T; Mischnik A; Karner M; Kreuter M; Roth W; Stremmel W; Merle U
    Z Gastroenterol; 2013 Oct; 51(10):1177-83. PubMed ID: 24122379
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alopecia areata in a patient with rheumatoid arthritis treated with leflunomide.
    Gottenberg JE; Venancie PY; Mariette X
    J Rheumatol; 2002 Aug; 29(8):1806-7. PubMed ID: 12180755
    [No Abstract]   [Full Text] [Related]  

  • 49. Partial response of severe alopecia areata to cyclosporine A.
    Ferrando J; Grimalt R
    Dermatology; 1999; 199(1):67-9. PubMed ID: 10449964
    [No Abstract]   [Full Text] [Related]  

  • 50. Letter: Alopecia areata during ustekinumab administration: Co-existence or an adverse reaction?
    Verros C; Rallis E; Crowe M
    Dermatol Online J; 2012 Jul; 18(7):14. PubMed ID: 22863636
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dinitrochlorobenzene therapy for alopecia areata.
    Happle R; Cebulla K; Echternacht-Happle K
    Arch Dermatol; 1978 Nov; 114(11):1629-31. PubMed ID: 152611
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists.
    Lee HH; Song IH; Friedrich M; Gauliard A; Detert J; Röwert J; Audring H; Kary S; Burmester GR; Sterry W; Worm M
    Br J Dermatol; 2007 Mar; 156(3):486-91. PubMed ID: 17300238
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors.
    Exarchou SA; Voulgari PV; Markatseli TE; Zioga A; Drosos AA
    Scand J Rheumatol; 2009; 38(5):328-31. PubMed ID: 19579151
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytokeratin expression in alopecia areata hair follicles.
    Van Baar HM; Van Vlijmen IM; Ramaekers FC; Van Muijen GN; Troyanovsky SM; Perret CM; Van de Kerkhof PC; Schalkwijk J
    Acta Derm Venereol; 1994 Jan; 74(1):28-32. PubMed ID: 7511864
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial.
    Braun J; Brandt J; Listing J; Zink A; Alten R; Burmester G; Golder W; Gromnica-Ihle E; Kellner H; Schneider M; Sörensen H; Zeidler H; Reddig J; Sieper J
    Arthritis Rheum; 2003 Aug; 48(8):2224-33. PubMed ID: 12905476
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Alopecia areata after biologic therapy: report of a case related to adalimumab].
    Neila J; Carrizosa A; Ceballos C; Camacho FM
    Actas Dermosifiliogr; 2011 Dec; 102(10):827-8. PubMed ID: 21798487
    [No Abstract]   [Full Text] [Related]  

  • 57. Successful treatment of infliximab-associated immune-mediated sensory polyradiculopathy with intravenous immunoglobulin.
    Naruse H; Nagashima Y; Maekawa R; Etoh T; Hida A; Shimizu J; Kaida K; Shiio Y
    J Clin Neurosci; 2013 Nov; 20(11):1618-9. PubMed ID: 23906523
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Abnormal hair growth in a patient with head and neck cancer treated with the anti-epidermal growth factor receptor monoclonal antibody cetuximab.
    Montagut C; Grau JJ; Grimalt R; Codony J; Ferrando J; Albanell J
    J Clin Oncol; 2005 Aug; 23(22):5273-5. PubMed ID: 16051981
    [No Abstract]   [Full Text] [Related]  

  • 59. Treatment of alopecia areata with sulfasalazine.
    Misery L; Sannier K; Chastaing M; Le Gallic G
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):547-8. PubMed ID: 17373991
    [No Abstract]   [Full Text] [Related]  

  • 60. Peptic ulcer disease in a patient with ankylosing spondylitis receiving a conventional nonsteroidal anti-inflammatory drug.
    Bannwarth B; Zerbib F
    Nat Clin Pract Rheumatol; 2006 Feb; 2(2):107-11;quiz 112. PubMed ID: 16932664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.